Patents by Inventor Maha Vishnu Mundla

Maha Vishnu Mundla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processes for the preparation of SGLT-2 inhibitors, intermediates thereof
    Patent number: 11548906
    Abstract: The present invention relates to modified, improved processes for the preparation of sodium glucose co-transporter 2 (SGLT-2) inhibitors and intermediates thereof. More particularly, the present invention relates to improved processes for the preparation of gliflozin compounds such as empagliflozin and dapagliflozin, intermediates thereof. The product obtained from the processes of present invention may be amorphous or crystalline. Also, the products obtained from the present invention may be used for the preparation of medicaments for the prevention and/or treatment of diseases and conditions associated with SGLT-2 inhibition.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: January 10, 2023
    Assignee: Emmennar Pharma Private Limited
    Inventors: Maha Vishnu Mundla, Laxmi Narasimha Varaprasad Chintaginjala, Suresh Kumar Gunukula, Prabhakar Bellam
  • PROCESSES FOR THE PREPARATION OF SGLT-2 INHIBITORS, INTERMEDIATES THEREOF
    Publication number: 20200331946
    Abstract: The present invention relates to modified, improved processes for the preparation of sodium glucose co-transporter 2 (SGLT-2) inhibitors and intermediates thereof. More particularly, the present invention relates to improved processes for the preparation of gliflozin compounds such as empagliflozin and dapagliflozin, intermediates thereof. The product obtained from the processes of present invention may be amorphous or crystalline. Also, the products obtained from the present invention may be used for the preparation of medicaments for the prevention and/or treatment of diseases and conditions associated with SGLT-2 inhibition.
    Type: Application
    Filed: May 18, 2020
    Publication date: October 22, 2020
    Inventors: Maha Vishnu MUNDLA, Laxmi Narasimha Varaprasad CHINTAGINJALA, Suresh Kumar GUNUKULA, Prabhakar BELLAM
  • Processes for the preparation of SGLT-2 inhibitors, intermediates thereof
    Patent number: 10703772
    Abstract: The present invention relates to novel, improved processes for the preparation of sodium glucose co-transporter 2 (SGLT-2) inhibitors and novel intermediates thereof. More particularly, the present invention relates to a novel, improved process for the preparation of gliflozin compounds such as empagliflozin and dapagliflozin, intermediates thereof. The product obtained from the processes of present invention may be amorphous or crystalline, or in the form of amorphous/crystalline solid dispersions/solutions with pharmaceutically acceptable polymers and preparation process thereof. Also, the products obtained from the present invention may be used for the preparation of medicaments for the prevention and/or treatment of diseases and conditions associated with SGLT-2 inhibition.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: July 7, 2020
    Assignee: Emmennar Pharma Private Limited
    Inventors: Maha Vishnu Mundla, Sridhar Malyala, Chandra Prakash Narani, Laxmi Narasimha Varaprasad Chintaginjala, Suresh Kumar Gunukula, Bala Yellaiah Chittiboyina, Prabhakar Bellam, Hemalatha Reddy Samireddy, Sowmya Dantham, Prasad Vure, Pooja Kale
  • Processes for the Preparation of SGLT-2 Inhibitors, Intermediates Thereof
    Publication number: 20180346502
    Abstract: The present invention relates to novel, improved processes for the preparation of sodium glucose co-transporter 2 (SGLT-2) inhibitors and novel intermediates thereof. More particularly, the present invention relates to a novel, improved process for the preparation of gliflozin compounds such as empagliflozin and dapagliflozin, intermediates thereof. The product obtained from the processes of present invention may be amorphous or crystalline, or in the form of amorphous/crystalline solid dispersions/solutions with pharmaceutically acceptable polymers and preparation process thereof. Also, the products obtained from the present invention may be used for the preparation of medicaments for the prevention and/or treatment of diseases and conditions associated with SGLT-2 inhibition.
    Type: Application
    Filed: May 29, 2018
    Publication date: December 6, 2018
    Inventors: Maha Vishnu Mundla, Sridhar Malyala, Chandra Prakash Narani, Laxmi Narasimha Varaprasad Chintaginjala, Suresh Kumar Gunukula, Bala Yellaiah Chittiboyina, Prabhakar Bellam, Hemalatha Reddy Samireddy, Sowmya Dantham, Prasad Vure, Pooja Kale